Story perspectives

New Study Links Cholesterol Metabolite to Parkinson's Progression

2/19/2025

48 6

Summary

Story summary

A groundbreaking study from Wuhan University reveals that 24-hydroxycholesterol (24-OHC), a cholesterol metabolite, fuels the progression of Parkinson's disease by enhancing the spread of harmful protein aggregates and causing neuron death. By inhibiting the enzyme CYP46A1 responsible for 24-OHC production, researchers successfully slowed disease advancement in mice, opening doors to innovative treatments for the 153,000 individuals battling Parkinson's in the UK.

1 of 1

Story summary

A groundbreaking study from Wuhan University reveals that 24-hydroxycholesterol (24-OHC), a cholesterol metabolite, fuels the progression of Parkinson's disease by enhancing the spread of harmful protein aggregates and causing neuron death. By inhibiting the enzyme CYP46A1 responsible for 24-OHC production, researchers successfully slowed disease advancement in mice, opening doors to innovative treatments for the 153,000 individuals battling Parkinson's in the UK.